|
Accueil > Actualité
Haleon: Pfizer continues getting out of capital
(CercleFinance.com) - Pfizer has sold a further 700 million ordinary shares in Haleon, its former joint venture with GSK in consumer healthcare products.
In a financial notice, Haleon states that the American pharmaceutical group placed its shares on the market at a unit price of 357 pence (or around $4.36), corresponding to total proceeds of some £2.5bn (or $3.05 billion). With this transaction, Pfizer's stake in Haleon will be reduced from 15% to 7.3%, as the American healthcare giant plans to eventually divest its entire stake, which initially stood at 32%. Copyright (c) 2025 CercleFinance.com. All rights reserved. |
23/05/2025 17:40
UbisoftBarclays détient moins de 5% du capital 23/05/2025 17:10 Legrandla société FIL détient plus de 5% du capital 23/05/2025 17:02 PublicisBlackRock détient plus de 5% des droits de votes 23/05/2025 16:50 AlstomBlackRock sous les 5% du capital & des votes 23/05/2025 16:00 J&Jprésentera 70 résumés lors du congrès de l'ASCO 23/05/2025 15:52 Generalien recul avec une dégradation d'analyste Tous les articles sociétés |
